Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bass Battled U.S. Drug Patents and Prices But Lost to ‘Cabal’
Bass Battled U.S. Drug Patents and Prices But Lost to ‘Cabal’
Bass Battled U.S. Drug Patents and Prices But Lost to ‘Cabal’
Submitted by
admin
on April 10, 2017 - 10:06am
Source:
Bloomberg
News Tags:
Kyle Bass
patents
drug pricing
AMPYRA
Acorda Therapeutics
multiple sclerosis
Headline:
Bass Battled U.S. Drug Patents and Prices But Lost to ‘Cabal’
Do Not Allow Advertisers to Use My Personal information
